About
Priyanka Yalamanchili graduated from Rutgers University with a Doctor of Pharmacy (PharmD)
degree in 2021 and Master of Science (MS) degree in Epidemiology with a concentration in
Pharmacoepidemiology in 2024. She completed her post-doctoral fellowship in
Pharmacoepidemiology with Rutgers Institute for Pharmaceutical Industry Fellowships and
Daiichi Sankyo. During her fellowship, she held an adjunct faculty position with the Ernest
Mario School of Pharmacy at Rutgers University. She is currently a manager of
pharmacoepidemiology at Daiichi Sankyo.
Research Profile
Pharmacoepidemiology, Oncology, Pediatrics, Pharmacovigilance
Selected Publications
- Yalamanchili P, Lee LY, Bushnell G, Mannion ML, Dave CV, Horton DB. Trends in
New Use of Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis
Among Commercially Insured Children in the United States from 2001-2022. Arthritis
Rheumatol. 2024. doi:10.1002/art.43041 - Yalamanchili P, Henderson M, Wang E, Salas M. Adverse Events in Patients Treated for
Colorectal Cancer in Published Phase III Clinical Trials: A Systematic Review and Meta-
Analysis. J Compr Cancer Res. 2024;4:100017. - Khasraw M, Yalamanchili P, Santhanagopal A, et al. Clinical Management of Patients
with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic
Alterations: A Systematic Literature Review. Adv Ther. 2024;41(5):1815-1842.
doi:10.1007/s12325-024-02799-9 - Henderson M, Yalamanchili P, Drinkwater C, et al. Perceptions, Experiences, and
Behaviors of Patients and their Caregivers with Gastric and Gastroesophageal Cancer
Treated with or without Trastuzumab Deruxtecan in the United States. Am J Health
Behav. 2024. doi:10.5993/AJHB.48.5.18 - Wang E, Henderson M, Yalamanchili P, et al. Potential biomarkers in breast cancer drug
development: application of the biomarker qualification evidentiary framework. Biomark
Med. 2024;18(6):265-277. doi:10.2217/bmm-2023-0048 - Salas M, Gossell-Williams M, Yalamanchili P, et al. The Use of Biomarkers in
Pharmacovigilance: A Systematic Review of the Literature. Biomark Insights.
2023;18:11772719231164528. doi:10.1177/11772719231164528 - Salas M, Petracek J, Yalamanchili P, et al. The Use of Artificial Intelligence in
Pharmacovigilance: A Systematic Review of the Literature. Pharmaceut Med.
2022;36(5):295-306. doi:10.1007/s40290-022-00441-z